Sourcia

Foundation date

2012

Sector

#Biotechnology / R&D Services

Subsector

Clinical Trial support (Full service - separate services )for SME and Biotech as well as Executive Support, Management Support

Upcoming events

Latest news

  • argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia

    21 hours ago

  • Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

    Wednesday November 22nd 2023

  • argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis

    Thursday November 16th 2023